Table 1.
Autism spectrum disorder | Healthy controls | |
---|---|---|
N | 437 | 511 |
Sex (M/F) | 382/55 | 419/92 |
% (M/F) | 87.4/12.5 | 82.0/18.0 |
Age (years) | 15.95 ± 6.17 | 16.12 ± 6.20 |
FSIQ Mean | 106.38 ± 14.18 | 111.07 ± 11.74 |
Intracranial Volume (mm3) | 1336,921 ± 272,115.55 | 1322,270 ± 254,188.55 |
Volumetric Amygdala Asymmetry | 185.21 ± 164.95 | 168.9 ± 141.56 |
Amygdala Shape Asymmetry | 2.13 ± 1.29 | 2.07 ± 1.14 |
Volumetric Hippocampal Asymmetry | 285.05 ± 398.59 | 259.35 ± 351.15 |
Hippocampal Shape Asymmetry | 2.15 ± 1.64 | 1.91 ± 1.14 |
Volumetric Ventricular Asymmetry | 1637.52 ± 1843.34 | 1300.51 ± 1403.56 |
Ventricular Shape Asymmetry | 3.76 ± 2.29 | 3.87 ± 2.34 |
Demographic information and summary statistics by diagnosis. Note: the ASD group is comprised of individuals diagnosed with all formerly used DSM-IV-TR subtypes, including 289 (66.1%) individuals diagnosed with Autism, 73 (16.7%) individuals diagnosed with Asperger's, 25 (5.7%) individuals diagnosed with Pervasive Development Disorder, and three (0.7%) individuals diagnosed as ASD-Not Otherwise Specified. DSM-IV-TR subtype information was not provided for 47 (11%) of ASD patients. Asymmetry values are non-directional.